4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · IEX Real-Time Price · USD
14.40
-0.74 (-4.89%)
At close: Jul 19, 2024, 4:00 PM
14.55
+0.15 (1.04%)
Pre-market: Jul 22, 2024, 7:29 AM EDT

4D Molecular Therapeutics Statistics

Total Valuation

FDMT has a market cap or net worth of $744.53 million. The enterprise value is $232.79 million.

Market Cap 744.53M
Enterprise Value 232.79M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date Aug 7, 2024
Ex-Dividend Date n/a

Share Statistics

FDMT has 51.70 million shares outstanding. The number of shares has increased by 50.57% in one year.

Shares Outstanding 51.70M
Shares Change (YoY) +50.57%
Shares Change (QoQ) +14.94%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 36.40
Forward PS 144.21
PB Ratio 1.24
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 11.38
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 32.65, with a Debt / Equity ratio of 0.02.

Current Ratio 32.65
Quick Ratio n/a
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -26.70% and return on invested capital (ROIC) is -19.67%.

Return on Equity (ROE) -26.70%
Return on Assets (ROA) -24.80%
Return on Capital (ROIC) -19.67%
Revenue Per Employee $139,129
Profits Per Employee -$711,265
Employee Count 147
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.00% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -20.00%
50-Day Moving Average 23.54
200-Day Moving Average 21.30
Relative Strength Index (RSI) 28.03
Average Volume (20 Days) 1,301,940

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, FDMT had revenue of $20.45 million and -$104.56 million in losses. Loss per share was -$2.44.

Revenue 20.45M
Gross Profit 20.45M
Operating Income -120.90M
Pretax Income -104.56M
Net Income -104.56M
EBITDA -98.63M
EBIT -104.56M
Loss Per Share -$2.44
Full Income Statement

Balance Sheet

The company has $525.91 million in cash and $14.17 million in debt, giving a net cash position of $511.74 million or $9.90 per share.

Cash & Cash Equivalents 525.91M
Total Debt 14.17M
Net Cash 511.74M
Net Cash Per Share $9.90
Equity (Book Value) 600.56M
Book Value Per Share 11.62
Working Capital 519.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$76.97 million and capital expenditures -$2.47 million, giving a free cash flow of -$79.44 million.

Operating Cash Flow -76.97M
Capital Expenditures -2.47M
Free Cash Flow -79.44M
FCF Per Share -$1.61
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -591.13% and -511.23%.

Gross Margin 100.00%
Operating Margin -591.13%
Pretax Margin -511.23%
Profit Margin -511.23%
EBITDA Margin -482.23%
EBIT Margin -511.23%
FCF Margin -388.44%

Dividends & Yields

FDMT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -50.57%
Shareholder Yield -50.57%
Earnings Yield -14.04%
FCF Yield -10.67%

Analyst Forecast

The average price target for FDMT is $48.25, which is 235.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target $48.25
Price Target Difference 235.07%
Analyst Consensus Strong Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 69.99%
EPS Growth Forecast (5Y) -0.88%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

FDMT has an Altman Z-Score of 14.71 and a Piotroski F-Score of 4.

Altman Z-Score 14.71
Piotroski F-Score 4